Study on integron drug resistance gene of ESBLs-prodcing Klebsiella pneumonia infection in ICU elderly patients
10.3969/j.issn.1673-4130.2016.16.004
- VernacularTitle:ICU老年患者感染产ESBLs肺炎克雷伯菌的整合子耐药基因研究
- Author:
Wei LIU
;
Jian CHEN
- Publication Type:Journal Article
- Keywords:
Klebsiella pneumoniae;
ICU;
ESBLs producing;
integron
- From:
International Journal of Laboratory Medicine
2016;37(16):2214-2216
- CountryChina
- Language:Chinese
-
Abstract:
Objective To understand the gene distribution and drug resistance rate of integron gene of extended spectrumβ‐lac‐tamases(ESBLs) producing Klebsiella pneumonia infection in ICU elderly patients in order to provide the basis for rational use of antimicrobial agents .Methods The BioMerieux VITEK‐2 Automated Microbes Identification System was adopted to conduct the bacteria identification and drug susceptibility test on various clinical specimens of ICU elderly patients in our hospital from January 2013 to December 2015 .The integron gene in 167 strains of ESBLs‐producing Klebsiella pneumoniae was analyzed by PCR ,and the gene was identified by sequencing .Results Among 386 strains of Klebsiella pneumoniae ,the detection rate of ESBLs‐producing strains was 43 .26% ;the positive rate of integron was 50 .89% ,the detected integron was class Ⅰ integron;aadA2 ,aadA1 ,aada16 , dfra27 and arr‐3 genes were amplified from integron variable region;the drug resistance rate of ESBLs‐producing integron gene pos‐itive strains was significantly higher than that of integron gene negative strains .Conclusion the ICU elderly patients with ESBLs‐producing Klebsiella pneumoniae infection is closely related to the integron gene and integron plays an important role in bacterial drug resistance .
